Download PDF
Nervenheilkunde 2009; 28(06): 378-381
DOI: 10.1055/s-0038-1628646
Thema zum Schwerpunkt
Schattauer GmbH

Komorbiditäten bei chronischen Kopfschmerzen

Theorie und Praxis Article in several languages: deutsch | English
T.-M. Wallasch
1   Klinik für Interdisziplinäre Schmerztherapie am Sankt Gertrauden Krankenhaus Berlin, Kopf-Schmerzzentrum, Lehrkrankenhaus der Charité
,
S. Förderreuther
2   Neurologische Klinik der Ludwig Maximilians Universität München, Neurologischer Konsiliardienst München
› Author Affiliations
Further Information

Publication History

eingegangen am: 30 September 2008

angenommen am: 14 October 2008

Publication Date:
24 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Migräne und andere chronisch verlaufende Kopfschmerzleiden weisen verschiedene Komorbiditäten auf. Bei Migränepatienten werden überzufällig häufig unspezifische kleine Läsionen im Marklager, ischämische Läsionen in der hinteren Strombahn oder ein persistierendes Foramen ovale nachgewiesen. Der pathophysiologische Stellenwert dieser Befunde ist bislang nicht geklärt. Für die Diagnostik oder Therapie von Migränepatienten ergeben sich hieraus keine Konsequenzen. Es gibt dagegen gute Evidenz dafür, dass Angsterkrankungen, Depressionen und möglicherweise auch Persönlichkeitsstörungen nicht nur gehäuft bei chronischen Kopfschmerzen auftreten, sondern auch bei deren Chronifizierung eine Schlüsselrolle spielen. Erste vorläufige Daten aus der Integrierten Versorgung Kopfschmerz Berlin geben einen Einblick in deren Versorgungsstrukturen und den Outcome einer multimodalen Therapie chronischer Kopfschmerzpatienten.

Schlüsselwörter

Komorbiditäten - chronische Kopfschmerzen - Migräne - Integrierte Versorgung
 

  • Literatur

  • 1 The International Classification of Headache Disorders: 2nd ed. Cephalalgia. 2004. 24 (suppl 1) 9-160.
    Google Scholar
  • 2 Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994; 44 (07) 1353-1354.
    CrossrefPubMedGoogle Scholar
  • 3 Adami A. et al. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 2008; 71 (02) 101-107.
    CrossrefPubMedGoogle Scholar
  • 4 Atasoy HT, Atasoy N, Unal AE. et al. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 2005; 09 (03) 285-291.
    CrossrefPubMedGoogle Scholar
  • 5 Beghi E. et al. Headache and anxiety-depressive disorder comorbidity: the HADAS study. Neurol Sci 2007; 28 (Suppl. 02) S217-219.
    CrossrefPubMedGoogle Scholar
  • 6 Breslau N, Davis GC. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia 1992; 12 (02) 85-90.
    CrossrefPubMedGoogle Scholar
  • 7 Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res 1993; 27 (02) 211-221.
    CrossrefPubMedGoogle Scholar
  • 8 Breslau N. et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60 (08) 1308-1312.
    CrossrefPubMedGoogle Scholar
  • 9 Breslau N. et al. Headache types and panic disorder: directionality and specificity. Neurology 2001; 56 (03) 350-354.
    CrossrefPubMedGoogle Scholar
  • 10 Breslau N. et al. Headache and major depression: is the association specific to migraine?. Neurology 2000; 54 (02) 308-313.
    CrossrefPubMedGoogle Scholar
  • 11 Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007; 20 (03) 310-319.
    CrossrefPubMedGoogle Scholar
  • 12 Dowson A. et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117 (11) 1397-1404.
    CrossrefPubMedGoogle Scholar
  • 13 Ferrari A. et al. Similarities and differences between chronic migraine and episodic migraine. Headache 2007; 47 (01) 65-72.
    CrossrefPubMedGoogle Scholar
  • 14 Guidetti V. et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998; 18 (07) 455-462.
    CrossrefPubMedGoogle Scholar
  • 15 Juang KD. et al. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000; 40 (10) 818-823.
    CrossrefPubMedGoogle Scholar
  • 16 Kruit MC. et al. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128 (09) 2068-2077.
    CrossrefPubMedGoogle Scholar
  • 17 Lewis DW. et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002; 59 (04) 490-498.
    CrossrefPubMedGoogle Scholar
  • 18 Lipton RB. et al. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000; 55 (05) 629-635.
    CrossrefPubMedGoogle Scholar
  • 19 Merikangas KR, Stevens DE, Angst J. Psychopathology and headache syndromes in the community. Headache 1994; 34 (08) S17-22.
    CrossrefPubMedGoogle Scholar
  • 20 Molgat CV, Patten SB. Comorbidity of major depression and migraine--a Canadian populationbased study. Can J Psychiatry 2005; 50 (13) 832-837.
    CrossrefPubMedGoogle Scholar
  • 21 Oedegaard KJ. et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006; 26 (01) 1-6.
    CrossrefPubMedGoogle Scholar
  • 22 Patten SB. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J Affect Disord 2001; 63 (1–3) 35-41.
    CrossrefPubMedGoogle Scholar
  • 23 Puca F. et al. Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia 1999; 19 (03) 159-164.
    Google Scholar
  • 24 Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005; 18 (03) 305-310.
    CrossrefPubMedGoogle Scholar
  • 25 Spierings EL, Ranke AH, Schroevers M. et al. Chronic daily headache: a time perspective. Headache 2000; 40 (04) 306-310.
    CrossrefPubMedGoogle Scholar
  • 26 Spierings EL, Schroevers M, Honkoop PC. et al. Development of chronic daily headache: a clinical study. Headache 1998; 38 (07) 529-533.
    CrossrefPubMedGoogle Scholar
  • 27 Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004; 61 (09) 1366-1368.
    CrossrefPubMedGoogle Scholar
  • 28 Wang SJ. et al. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 2007; 68 (08) 591-596.
    CrossrefPubMedGoogle Scholar
  • 29 Wiendels NJ. et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006; 26 (12) 1434-1442.
    CrossrefPubMedGoogle Scholar
  • 30 Wilmshurst PT. et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90 (11) 1315-1320.
    CrossrefPubMedGoogle Scholar
  • 31 Zwart JA. et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003; 10 (02) 147-152.
    CrossrefPubMedGoogle Scholar
  • 32 Zwart JA. et al. Analgesic use: a predictor of chronic pain and medication overuse headache: the HeadHUNT Study. Neurology 2003; 61 (02) 160-164.
    CrossrefPubMedGoogle Scholar